Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b.
As the incidence of melanoma continues to increase, oncology nurses will be caring for more patients receiving adjuvant alpha interferon-2b. Managing the side effects from this therapy requires expert nursing care. The nurse's role throughout the year-long therapy is critical to ensure the patient's continued adherence to the treatment schedule.
Kiley
K E
KE
Loyola University Medical Center, Maywood, IL, USA.
Gale
D M
DM
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000451:nursing*; D009730:Nursing Assessment; D009859:Oncology Nursing; D010353:Patient Education as Topic; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000451:nursing*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins